These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7494781)

  • 21. Potentiation by a progrestational agent of liver damage induced by a hepatotoxic agent.
    Joshi UM; Rao SS
    Indian J Exp Biol; 1969 Apr; 7(2):79-81. PubMed ID: 5798615
    [No Abstract]   [Full Text] [Related]  

  • 22. There are many benzo-pyrones for lymphedema.
    Casley-Smith JR
    Lymphology; 1997 Mar; 30(1):38-9. PubMed ID: 9106139
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats.
    Murat Bilgin H; Atmaca M; Deniz Obay B; Ozekinci S; Taşdemir E; Ketani A
    Exp Toxicol Pathol; 2011 May; 63(4):325-30. PubMed ID: 20207117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of coumarin hepatotoxicity.
    Casley-Smith JR; Casley-Smith JR
    Med J Aust; 1995 Apr; 162(7):391. PubMed ID: 7715532
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute liver cell degeneration with hepatorenal syndrome in monocoumarolin intoxication].
    Stark U; Zalaudek G; Samec H; Sterz H
    Wien Med Wochenschr; 1971 Apr; 121(17):358-61. PubMed ID: 5575103
    [No Abstract]   [Full Text] [Related]  

  • 26. [The liver disease in the toxic oil syndrome. Development after a year follow-up].
    Mearin F; Moreno Otero R; Rodríguez S; Del Pozo A; García-Méndez JA; Pájares JM
    Rev Esp Enferm Apar Dig; 1983 Jan; 63(1):76-82. PubMed ID: 6135243
    [No Abstract]   [Full Text] [Related]  

  • 27. Coumarin-Induced Hepatotoxicity: A Narrative Review.
    Pitaro M; Croce N; Gallo V; Arienzo A; Salvatore G; Antonini G
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enzyme diagnosis and liver diseases].
    Schmidt E; Schmidt FW
    Schweiz Med Wochenschr; 1969 Apr; 99(15):514-21. PubMed ID: 5784493
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone.
    Casley-Smith JR; Morgan RG; Piller NB
    N Engl J Med; 1993 Oct; 329(16):1158-63. PubMed ID: 8377779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behavior of gamma glutamyl transpeptidase in hepatobiliary diseases].
    Kresbach E; Thurnher H
    Wien Med Wochenschr; 1973 Apr; 123(16):253-8. PubMed ID: 4144931
    [No Abstract]   [Full Text] [Related]  

  • 31. [Health impairment caused by coumarin?].
    Schwietzer CH
    Dtsch Med Wochenschr; 1972 Oct; 97(41):1573. PubMed ID: 5075801
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of gamma-glutamyl transferase (GGT) activity measurements in alcohol-induced hepatic injury.
    Boone DJ; Tietz NW; Weinstock A
    Ann Clin Lab Sci; 1977; 7(1):25-8. PubMed ID: 13703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticlopidine-induced elevated liver enzymes.
    Klepser TB; Jogerst GJ
    Pharmacotherapy; 1997; 17(4):819-21. PubMed ID: 9250564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum xanthine oxidase and liver disease.
    Ramboer C; Piessens F; De Groote J
    Digestion; 1972; 7(3):183-95. PubMed ID: 4671513
    [No Abstract]   [Full Text] [Related]  

  • 35. [Change in enzyme activity in experimental acute hepatic insufficiency].
    Lokshin LS; Pustovalova LM
    Eksp Khir Anesteziol; 1973; 18(3):40-2. PubMed ID: 4773559
    [No Abstract]   [Full Text] [Related]  

  • 36. Diurnal variation of serum alanine transaminase activity in chronic liver disease.
    Córdoba J; O'Riordan K; Dupuis J; Borensztajin J; Blei AT
    Hepatology; 1998 Dec; 28(6):1724-5. PubMed ID: 9890798
    [No Abstract]   [Full Text] [Related]  

  • 37. [Morphological and functional changes in the liver after intravenous injections of glucose and fructose in the rat].
    Orcel L; Giboudeau J; Roland J
    Pathol Eur; 1970; 5(4):377-83. PubMed ID: 5515045
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate.
    Raab WP
    Arzneimittelforschung; 1971 Oct; 21(10):1620-1. PubMed ID: 5171899
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
    Tamura S; Warabi Y; Matsubara S
    J Clin Pharm Ther; 2012 Dec; 37(6):724-5. PubMed ID: 22642738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatotoxicity associated with maprotiline therapy: case report.
    Moldawsky RJ
    J Clin Psychiatry; 1984 Apr; 45(4):178-9. PubMed ID: 6715293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.